ETRADE Capital Management LLC grew its stake in Bruker Co. (NASDAQ:BRKR) by 10.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 29,484 shares of the medical research company’s stock after purchasing an additional 2,701 shares during the quarter. ETRADE Capital Management LLC’s holdings in Bruker were worth $877,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of BRKR. Alps Advisors Inc. grew its position in shares of Bruker by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 20,154 shares of the medical research company’s stock valued at $581,000 after buying an additional 52 shares during the last quarter. Utah Retirement Systems grew its position in shares of Bruker by 1.1% during the 2nd quarter. Utah Retirement Systems now owns 19,189 shares of the medical research company’s stock valued at $553,000 after buying an additional 200 shares during the last quarter. Federated Investors Inc. PA grew its position in shares of Bruker by 0.3% during the 2nd quarter. Federated Investors Inc. PA now owns 60,553 shares of the medical research company’s stock valued at $1,746,000 after buying an additional 204 shares during the last quarter. Tudor Investment Corp ET AL grew its position in shares of Bruker by 1.5% during the 2nd quarter. Tudor Investment Corp ET AL now owns 15,980 shares of the medical research company’s stock valued at $461,000 after buying an additional 242 shares during the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in shares of Bruker by 7.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 5,003 shares of the medical research company’s stock valued at $144,000 after buying an additional 331 shares during the last quarter. Institutional investors and hedge funds own 65.58% of the company’s stock.

In other news, VP Mark Munch sold 21,061 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $29.97, for a total value of $631,198.17. Following the completion of the sale, the vice president now directly owns 60,524 shares of the company’s stock, valued at approximately $1,813,904.28. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 35.20% of the company’s stock.

BRKR has been the subject of several recent analyst reports. Zacks Investment Research cut shares of Bruker from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. Citigroup upped their target price on shares of Bruker from $29.00 to $34.00 and gave the stock a “neutral” rating in a research report on Friday, November 3rd. Cowen restated a “hold” rating and issued a $29.00 target price on shares of Bruker in a research report on Friday, November 3rd. Bank of America upgraded shares of Bruker from an “underperform” rating to a “neutral” rating and set a $34.00 target price for the company in a research report on Friday, November 3rd. Finally, J P Morgan Chase & Co upgraded shares of Bruker from an “underweight” rating to a “neutral” rating and set a $28.00 target price for the company in a research report on Friday, November 3rd. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. Bruker currently has a consensus rating of “Hold” and an average price target of $29.64.

Shares of Bruker Co. (NASDAQ:BRKR) traded up $0.05 during trading hours on Friday, hitting $35.18. 729,900 shares of the stock were exchanged, compared to its average volume of 631,908. The firm has a market cap of $5,470.00, a price-to-earnings ratio of 31.07, a P/E/G ratio of 3.07 and a beta of 1.05. Bruker Co. has a 12 month low of $21.03 and a 12 month high of $36.53. The company has a current ratio of 2.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.65.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, November 2nd. The medical research company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.02. The company had revenue of $435.60 million during the quarter, compared to analyst estimates of $415.45 million. Bruker had a net margin of 8.85% and a return on equity of 25.83%. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.32 EPS. equities analysts forecast that Bruker Co. will post 1.19 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 22nd. Stockholders of record on Monday, December 4th will be paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend is Friday, December 1st. Bruker’s dividend payout ratio is currently 17.02%.

ILLEGAL ACTIVITY WARNING: This article was first reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.dailypolitical.com/2017/12/01/bruker-co-brkr-holdings-boosted-by-etrade-capital-management-llc.html.

About Bruker

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Co. and related companies with MarketBeat.com's FREE daily email newsletter.